Cue Health
(NASDAQ:HLTH)
$0.104
-0.0137[-11.64%]
At close: May 17
$0.104
0[0.00%]
After Hours: 7:59PM EDT
Consensus Rating1
Neutral
Highest Price Target1
$0.00
Lowest Price Target1
$0.00
Consensus Price Target1
$3.88

Cue Health Stock (NASDAQ:HLTH), Analyst Ratings, Price Targets, Predictions

Cue Health Inc has a consensus price target of $3.88, established from looking at the 17 latest analyst ratings. The last 3 analyst ratings were released from BTIG, Goldman Sachs, and Goldman Sachs on March 14, 2024, November 10, 2023, and June 5, 2023. With an average price target of $0.42 between BTIG, Goldman Sachs, and Goldman Sachs, there's an implied 300.64% upside for Cue Health Inc from these 3 analyst ratings.

Analyst Trend
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
2.7
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

BTIG
Goldman Sachs
Cowen & Co.
Morgan Stanley

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Cue Health

Buy NowGet Alert
03/14/2024Buy NowBTIG
Mark Massaro
DowngradeBuy → NeutralGet Alert
11/10/2023Buy Now380.77%Goldman Sachs
Matthew Sykes
$0.75 → $0.5MaintainsNeutralGet Alert
06/05/2023Buy Now621.15%Goldman Sachs
Matthew Sykes
$2.75 → $0.75MaintainsNeutralGet Alert
06/02/2023Buy Now621.15%Goldman Sachs
Matthew Sykes
$2.75 → $0.75DowngradeBuy → NeutralGet Alert
05/15/2023Buy Now2784.62%BTIG
Mark Massaro
$5 → $3MaintainsBuyGet Alert
05/01/2023Buy Now2784.62%Goldman Sachs
Matthew Sykes
$3.5 → $3MaintainsBuyGet Alert
03/16/2023Buy Now4707.69%BTIG
Mark Massaro
→ $5MaintainsBuyGet Alert
11/14/2022Buy Now6630.77%Cowen & Co.
Charles Rhyee
$9 → $7MaintainsOutperformGet Alert
11/09/2022Buy Now6630.77%BTIG
Mark Massaro
→ $7MaintainsBuyGet Alert
10/21/2022Buy Now5669.23%Goldman Sachs
Matthew Sykes
$7 → $6MaintainsBuyGet Alert
08/12/2022Buy Now8553.85%BTIG
Mark Massaro
$11 → $9MaintainsBuyGet Alert
08/11/2022Buy Now7592.31%Morgan Stanley
Tejas Savant
$10 → $8MaintainsEqual-WeightGet Alert
05/12/2022Buy Now9515.38%Morgan Stanley
Tejas Savant
$11 → $10MaintainsEqual-WeightGet Alert
03/30/2022Buy Now10476.92%Morgan Stanley
Tejas Savant
$12 → $11MaintainsEqual-WeightGet Alert
10/19/2021Buy Now11438.46%Morgan Stanley
Tejas Savant
Initiates → Equal-WeightGet Alert
10/19/2021Buy Now18169.23%Goldman Sachs
Matthew Sykes
Initiates → BuyGet Alert
10/19/2021Buy Now13361.54%Cowen & Co.
Charles Rhyee
Initiates → OutperformGet Alert

FAQ

Q

What is the target price for Cue Health (HLTH)?

A

The latest price target for Cue Health (NASDAQ: HLTH) was reported by BTIG on March 14, 2024. The analyst firm set a price target for $0.00 expecting HLTH to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Cue Health (HLTH)?

A

The latest analyst rating for Cue Health (NASDAQ: HLTH) was provided by BTIG, and Cue Health downgraded their neutral rating.

Q

When was the last upgrade for Cue Health (HLTH)?

A

There is no last upgrade for Cue Health.

Q

When was the last downgrade for Cue Health (HLTH)?

A

The last downgrade for Cue Health Inc happened on March 14, 2024 when BTIG changed their price target from N/A to N/A for Cue Health Inc.

Q

When is the next analyst rating going to be posted or updated for Cue Health (HLTH)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cue Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cue Health was filed on March 14, 2024 so you should expect the next rating to be made available sometime around March 14, 2025.

Q

Is the Analyst Rating Cue Health (HLTH) correct?

A

While ratings are subjective and will change, the latest Cue Health (HLTH) rating was a downgraded with a price target of $0.00 to $0.00. The current price Cue Health (HLTH) is trading at is $0.10, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch